Article

CAR T-cell therapy - Paving the way for sensitized kidney transplant patients

2023-08-26

Abstract excerpt

<h4>ABSTRACT</h4> Anti-HLA donor specific antibodies have been extensively documented for their critical role in kidney transplant rejection and resulting adverse outcomes. Several approaches have been employed to desensitize these patients; however, none of these explored therapeutic approaches has exhibited enduring clinical benefits. In this study, we explore a novel strategy of utilizing chimeric antigen rece...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4b35a37c-66d7-5f3c-95f9-e593c0dbb6ef
DOI: 10.1101/2023.08.24.554644

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CAR T-cell therapy - Paving the way for sensitized kidney transplant patientsDOI 10.1101/2023.08.24.554644Read

Depletion of alloreactive B cells by chimeric alloantigen receptor T cells with drug resistance to prevent antibody-mediated rejection in solid organ transplantationSemantic proximity Read

Depletion of alloreactive B cells by drug-resistant chimeric alloantigen receptor T cells to prevent transplant rejectionSemantic proximity Read

Chimeric anti-HLA antibody receptor engineered human regulatory T cells suppress alloantigen-specific B cells from pre-sensitized transplant recipientsSemantic proximity Read

Chimeric HLA antibody receptor T cells for targeted therapy of antibody-mediated rejection in transplantation.Semantic proximity Read

Regulatory B cells: the cutting edge of immune tolerance in kidney transplantationSemantic proximity Read

Engineering the Graft–Immune Interface: CAR-T Cell Strategies for Precision Organ TransplantationSemantic proximity Read

Tolerance in Kidney Transplantation: What Is on the B Side?Semantic proximity Read

Identification of a Highly Functional Effector CD8 <sup>+</sup> T Cell Program after Transplantation in Mice and HumansSemantic proximity Read

Chimeric Antigen Receptor T-Cell Therapy: What We Expect SoonSemantic proximity Read

A new therapeutic pathway in autoimmune diseases: chimeric antigen receptor T cells (CAR-T) targeting specific cell subtypes or antigen-specific B lymphocytes—a brief reviewSemantic proximity Read

Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challengesSemantic proximity Read

Novel strategies to target the humoral alloimmune response.Semantic proximity Read